StreetAlpha.app
Home › Stocks › WGS

GeneDx Holdings Corp. (WGS)

Healthcare
$47.29
▼ −7.31%
LAST CLOSE · NOV 17

GeneDx offers exome and genome tests for clinicians and provides genomic data for biopharma research, based in Stamford, Connecticut. It last closed at $47.29 on Nov 17, down 7.31% on the day. WGS last reported earnings on Mon, Nov 9, 2026. The average 12-month price target from 2 analysts is $84.00 (+77.6% from the last close), with a high of $85.00 and a low of $83.00. Over the past 90 days StreetAlpha recorded 11 whale options trades in WGS, 64% of them bullish and 36% bearish.

AI Auto Pilots
Is WGS in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$460.8M
+14.6% vs a year ago
Net income
−$111.0M
−5431.2% vs a year ago
EPS (diluted)
−$3.76
−3518.2% vs a year ago
Free cash flow
−$101.2M
−22.0% margin
Valuation
Market cap
$1.4B
30.0M shares
P/E
–
No P/E while losing money
Price to sales
3.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$96.1M
At Sep 30
Debt
$150.0M
At Sep 30
Shareholder equity
$244.7M
Shares outstanding
30.0M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $212.2M$212.2MFY2021FY2022: $234.7M$234.7MFY2022FY2023: $202.6M$202.6MFY2023FY2024: $305.4M$305.4MFY2024FY2025: $427.5M$427.5MFY2025

From WGS's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Last report
Nov 9
2026 · After the close (AMC)
Reported EPS
$0.28
vs $0.07 est. · beat
Year-ago EPS
$0.49
Same quarter last year
Options-implied move
±23.9%
Priced in before that report
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated WGS in the past 90 days, not enough for a consensus
Average 12-month target
$84.00
▲ 77.6% upside

Based on 2 analysts who set a price target on WGS in the past 90 days. The average target is $84.00, with a high of $85.00 and a low of $83.00, compared with the last close of $47.29.

Low $83.00Avg $84.00High $85.00
Blue marker: last close $47.29
Highest target$85.00
Average target$84.00
Lowest target$83.00
Latest rating changes
BTIGTarget lowered
Nov 10Buy$90 → $85
GuggenheimTarget raised
Oct 1Buy$74 → $83
Canaccord GenuityMaintained
Aug 4Buy$90
BTIGReiterated
Aug 4Buy$90
GuggenheimMaintained
Jun 29Buy$74
DateFirmActionRatingPrice target
Nov 10BTIGTarget loweredBuy$90 → $85
Oct 1GuggenheimTarget raisedBuy$74 → $83
Aug 4Canaccord GenuityMaintainedBuy$90
Aug 4BTIGReiteratedBuy$90
Jun 29GuggenheimMaintainedBuy$74
Loading…

Technical Analysis

WGS · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 30% below its 20 day and 53% below its 50 day average. It is 47% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the Pivot S1 at $43.79, and the nearest resistance the Pivot at $47.74.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 12.5%/day
Key levels
$170.8752 week high+261.3%
$72.87100 day average+54.1%
$72.3650 day average+53.0%
$69.41200 day average+46.8%
$61.4020 day average+29.8%
$57.15Swing high (Jun 4)+20.9%
$51.23Pivot R1+8.3%
$47.74Pivot+1.0%
$47.29Last close
$43.79Pivot S1−7.4%
$32.2152 week low−31.9%
Indicators
RSI (14)31.99Weak, oversold below 30Neutral
MACD-5.55Below its signal lineBearish
Stochastic13.6Near the bottom of its rangeOversold
ADX (14)29.9Trending down
Williams %R-88.8Oversold below −80, overbought above −20Oversold
CCI (20)-158.8Oversold below −100, overbought above 100Oversold
Rate of change−31.1%Change over 10 sessionsBearish
ATR (14)$5.91Typical daily range, 12.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for WGS

What happened before

See how WGS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish7 bullish and 4 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow WGS usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How WGS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
11
Bullish
7
64%
Bearish
4
36%
Date span
Oct 15 – Nov 16
Loading…

See today’s whale options flow across the market →

WGS Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼112 buying vs 135 selling
  • ▼Held by funds -5.0 pts
  • ▼Funds holding -20
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding220240−8.3%
In funds' top 1056−16.7%
Held by funds112.6%117.6%−5.0 pts
New / increased45 / 6755 / 89−22.2%
Reduced / sold out69 / 6656 / 72+5.5%
Put/call ratio1.040.17+521.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See WGS institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WGS is in one of them and how their past WGS trades turned out.

WGS in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered WGS in an article yet. Here's the latest on the wider market.

About GeneDx Holdings

GeneDx is a genetic testing company based in Stamford, Connecticut. It offers exome and genome tests that help clinicians diagnose genetic conditions, with a focus on pediatric patients. Its customers include geneticists, pediatric specialists, general pediatricians and other healthcare providers. The company also partners with biopharmaceutical companies that use its genomic data for research and discovery.

Headquarters
Stamford, CT